A Histologically Complete Response to Immunotherapy Using Pembrolizumab in a Patient with Giant Cell Carcinoma of the Lung: An Additional Report and Literature Review

We previously reported a case of giant cell carcinoma in the lung, in which the use of antiprogrammed death 1 (PD-1) immunotherapy resulted in substantial tumor reduction. In the present study, we describe an additional clinical course. A 69-year-old woman was diagnosed with giant cell carcinoma of...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Case Rep Oncol Med
Main Authors: Kakimoto, Tomoo, Sasaki, Mamoru, Yamamoto, Tatsuya, Iwamaru, Arifumi, Ogata, Kentaro, Lee, Ko, Nakayama, Shingo, Minematsu, Naoto
פורמט: Artigo
שפה:Inglês
יצא לאור: Hindawi 2019
נושאים:
Case Report
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6815550/
https://ncbi.nlm.nih.gov/pubmed/31737389
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/1763625
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים